Michael Hartmann

Title: Inventor Michael Hartmann: Innovations in Biotechnology

Introduction

Michael Hartmann, a noted inventor based in Bielefeld, Germany, has made significant contributions to the field of biotechnology. With three patents to his name, Hartmann's work primarily focuses on innovations related to the production of amino acids and gene sequences that enhance biotechnological processes.

Latest Patents

Among his latest patents are two notable inventions. The first relates to a nucleotide sequence encoding the dapC gene, which is pivotal for the production of L-lysine. This invention encompasses an isolated polynucleotide derived from coryneform bacteria. The second patent involves the isolation of a polynucleotide that encodes a protein responsible for n-succinylaminoketopimelate transaminase activity. These patents reflect Hartmann's expertise in genetic engineering and its application in industrial biotechnology.

Career Highlights

Throughout his career, Michael Hartmann has been associated with prestigious companies in the biotechnology sector, such as Degussa Aktiengesellschaft and Evonik Degussa GmbH. These affiliations have provided him with extensive experience in research and development, enabling him to innovate in the realm of biotechnology effectively.

Collaborations

Hartmann has collaborated with various esteemed professionals in his field, including notable figures such as Walter Pfefferle and Alfred Pühler. These collaborations have fostered an environment of creativity and innovation, further advancing his work in the development of patented technologies.

Conclusion

In conclusion, Michael Hartmann is a distinguished inventor whose patented innovations demonstrate his commitment to advancing biotechnology. His contributions to understanding gene sequences and the production of essential amino acids position him as an influential figure in the industry, promising continued advancements in biotechnological processes.